June 8, 2017August 24, 2022
Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

The MEK inhibitor Mekinist (trametinib) is to be tested in combination with Opdivo (nivolumab) — or Opdivo plus Yervoy (ipilimumab) — in colorectal cancer ... Read more
June 6, 2017
Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Certain patients who underwent surgery for lymph-node positive colon cancer (stage 3) may require only three months of chemotherapy after surgery ... Read more
June 1, 2017June 1, 2017
Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

The MEK inhibitor binimetinib will soon be tested in combination with Opdivo (nivolumab) plus Yervoy (ipilimumab) in colorectal cancer patients ... Read more
May 30, 2017
PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

Trovagene’s PCM-075 therapy for several blood cancers and solid tumors, including colon cancer, proved safe in a Phase 1 clinical ... Read more
May 25, 2017May 25, 2017
FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Colorectal cancer patients with unresectable or metastatic tumors bearing a genetic feature — microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) — ... Read more
May 23, 2017
Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Overweight boys have a higher risk of developing colon cancer in adulthood, but if they lose the extra pounds by ... Read more
May 18, 2017May 18, 2017
Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Tom Marsilje, who survived stage IV colorectal cancer (CRC), has joined forces with New York-based Fight Colorectal Cancer to help patients search for ... Read more
May 16, 2017
Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

The Colon Cancer Coalition, a nonprofit organization that encourages grassroots efforts to promote colon cancer awareness and screening, is partnering ... Read more
May 11, 2017
Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

A new European project aims to develop an innovative endoscope device that can detect and diagnose colorectal cancer in its early ... Read more
May 9, 2017
Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

People who eat healthy, exercise, and do not smoke are less likely to report a personal history of colorectal cancer ... Read more
May 4, 2017May 4, 2017
RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

Small molecule compounds known as RLR agonists, being developed by Kineta to treat colon cancer, were seen to kill cancer ... Read more
May 2, 2017May 2, 2017
New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research

MIT researchers using the CRISPR-Cas9 genome editing and organoid technology have developed a new mouse model with a cancer that ... Read more

May 11, 2015May 11, 2015

Anti-Cancer Stem Cell OH14 Licensed to Tiziana from Cardiff University

A new compound developed in a laboratory at Cardiff University holds great potential for fighting colon cancer. The compound, OH14, in now under license at Tiziana Life Sciences, which is ... Read more

May 8, 2015May 8, 2015

US San Diego School of Medicine Researchers Find That Patients With GISTs are More Likely to Develop Other Cancers

In a recent study published in the journal Cancer, a research team from UC San Diego School of Medicine conducted the first population-based study characterizing the association and temporal relationship between ... Read more

May 6, 2015May 6, 2015

Novel Anticancer Small Molecule Could Overcome Treatment Resistance in Colorectal Cancer

In a recent study published in the journal Molecular Cancer, a research team led by Fengzhi Li, PhD, of Roswell Park Cancer Institute (RPCI) found that a novel anticancer small ... Read more

May 4, 2015May 4, 2015

PlasmaTech’s ProctiGard Can Prevent Radiation Therapy Side-Effects in Colon Cancer Patients

The National Cancer Institute at the National Institutes of Health estimates that there are more than 250,000 new cases of colon, rectal, bladder, cervical, prostate, testicular and endometrial cancer diagnosed ... Read more

May 1, 2015May 1, 2015

FDA Approves New Monoclonal Antibody For Colon Cancer Treatment

The U. S. Food and Drug Administration (FDA) has recently approved a new drug for colon cancer. According to an announcement on the FDA website, the approval has been granted for ... Read more

April 30, 2015April 30, 2015

Two-Week International Diet Swap Reveals Potential Effects Of Food On Colon Cancer Risk

According to an international study published in Nature Communications conducted by scientists at the University of Pittsburgh School of Medicine, African-Americans and Africans who swapped their regular diets for just 2 weeks altered their risks of developing colon ... Read more

April 29, 2015April 29, 2015

Researchers Identify Toxic Mushroom-Based Drug To Fight Colorectal Cancer

A toxin called alpha-amanatin, derived from “death cap” mushrooms was considered for some time as a potential treatment for colorectal cancer. But since the toxin is known to cause liver toxicity, ... Read more

April 28, 2015April 28, 2015

FDA Highlights Higher Incidence of Colorectal Cancer in Minorities

The U.S. Food and Drug Administration (FDA) recently published an article highlighting the incidence of colorectal cancer, particularly among minorities. The study entitled “Colorectal Cancer: What You Should Know” was published ... Read more

April 27, 2015April 27, 2015

Silibinin from Milk Thistle Extract Halts Colon Cancer Stem Cells

A nontoxic chemical extracted from milk thistle, a purple flower that grows around the world, may help stop the growth of colon cancer stem cells. Silibinin, the purified chemical, was shown ... Read more

April 24, 2015April 27, 2015

Colorectal Cancer Metabolism Regulated by Specific Long Non-Coding RNA Molecule

The University of Texas MD Anderson Cancer Center recently announced that a collaborative study involving MD Anderson researchers discovered that a specific RNA molecule is capable of regulating cancer metabolism ... Read more

April 23, 2015April 27, 2015

Novel Biomarkers for Colorectal Cancer Detection Discovered

Due to the low response rates of colorectal cancer patients for different drug regimens, a team of researchers at Champions Oncology and InSilico Medicine examined if biomarkers and biological signals in ... Read more

April 22, 2015April 22, 2015

A New Cold Plasma Apparatus To Kill Cancer Cells In Colon Cancer

A new cold plasma device, Canady Helios Cold Plasma Scalp, developed by the US Medical Innovations (USMI) family of companies, was used in a patient diagnosed with inoperable colon cancer. The ... Read more

Clinical Trial to Test Mekinist as Combo Therapy in Advanced Colorectal Cancer Patients

Certain Colon Cancer Patients May Need a Shorter Chemotherapy Course, International Study Finds

Binimetinib Triple Combo to Be Tested in Microsatellite Stable Colorectal Cancer Patients

PCM-075 Proves Safe as Treatment for Colon, Other Cancer Types, Phase 1 Trial Shows

FDA Approves Merck’s Keytruda for Colorectal, Other Solid Cancers with Specific Genetic Feature

Increased Colon Cancer Risk in Overweight Boys Reversed by Slimming Down, Danish Study Finds

Stage IV Colorectal Cancer Survivor Updates Microsatellite Stable CRC Clinical Trial Finder

Colon Cancer Coalition Partnering with Olympus to Try to Increase the Disease’s US Screening Rate

Researchers Take Aim at Early-stage Colon Cancer by Working on New Endoscope Device

Online Survey Shows What Lifestyle Changes People Can Make to Reduce Risk of Colon Cancer

RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study

New MIT Mouse Model Using CRISPR Technology Could Speed Up Colon Cancer Research